Loomis, Sayles and »

BioMarin Pharmaceutical shares owned by Loomis, Sayles and

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Loomis, Sayles and from 13F filings

Historical chart of Loomis, Sayles and investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Loomis, Sayles and consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Loomis, Sayles and

Quarter filed Position value Share count Share price at filing
2012-09-30 $17k 430 39.53

More positions owned by Loomis, Sayles and

Meta Platforms Common (META)
Nvidia Corp Common (NVDA)
Amazon.com Common (AMZN)
Tesla Common (TSLA)
Alphabet Inc-cl A Common (GOOGL)
Visa Inc-class A Shrs Common (V)
Microsoft Corp Common (MSFT)
Boeing Common (BA)
Oracle Corp Common (ORCL)
Netflix.com Common (NFLX)
Salesforce.com Common (CRM)
Monster Beverage Corporation Common (MNST)
Autodesk Common (ADSK)
The Walt Disney Common (DIS)
Vertex Pharmaceuticals Common (VRTX)

View all positions for Loomis, Sayles and

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical